First, we will look at the clinical trials conducted by this company, which operates in the biopharmaceutical sector, with the results published for each phase and the launch of new tests.
As mentioned earlier in this page, UCB Pharma is a Belgian-based company. As such, its shares are currently listed on the Euronext Brussels market alongside the other major Belgian stock market capitalisations and in compartment A of this financial centre. UCB Pharma is also part of the composition of the Belgian benchmark stock market index, the BEL 20, and is therefore one of the 20 most highly capitalised Belgian companies.